Collar Capital Management
ABBV icon

Collar Capital Management’s AbbVie ABBV Stock Holding History

Collar Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$4.3M Buy
16,436
+1,053
+7% +$270K 2.57% 11
2026
Q2 		$3.87M Sell
15,383
-8
-0.1% -$1.72K 2.28% 10
2026
Q1 		$3.35M Buy
15,391
+84
+0.5% +$18.6K 2.17% 17
2025
Q4 		$3.5M Buy
15,307
+4,065
+36% +$926K 2.34% 13
2025
Q3 		$2.6M Hold
11,242
– – 1.83% 22
2025
Q2 		$2.09M Buy
11,242
+34
+0.3% +$6.32K 1.76% 21
2025
Q1 		$2.35M Buy
11,208
+4,076
+57% +$792K 2.13% 14
2024
Q4 		$1.27M Buy
+7,132
New +$1.31M 1.06% 41

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $40B AUM 30.45% 1-Year Est. Return
B. Metzler seel. Sohn & Co
B. Metzler seel. Sohn & Co Frankfurt, Germany $11.5B AUM 29.17% 1-Year Est. Return

Collar Capital Management's ABBV Position: Q3 2026 in Review

Collar Capital Management increased its AbbVie (ABBV) stake by 6.8% in Q3 2026, buying an estimated $270K and bringing the position to 16,436 shares worth $4.3M. The position accounts for 2.57% of the portfolio, ranked #11.

Collar Capital Management first reported a position in ABBV in Q4 2024 and has held it in 8 quarters since. 1,999 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Collar Capital Management held 16,436 shares of AbbVie worth $4.3M as of Q3 2026.
  • Collar Capital Management bought 1,053 AbbVie shares in Q3 2026, an estimated $270K.
  • AbbVie made up 2.57% of Collar Capital Management's portfolio in Q3 2026, its #11 holding.
  • Collar Capital Management first reported a position in AbbVie in Q4 2024 and has held it in 8 quarters since.
  • 1,999 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Collar Capital Management's 13F filing for Q3 2026, filed 28 Oct 2026.